What prompts you to seek an alternative PPI versus escalating to PCAB therapy in patients with symptoms and sequelae of GERD who have clinically failed one PPI trial despite appropriate pre-prandial use?

Considering PCABs appear to have superiority over PPIs in the treatment of various acid-related disorders, including erosive esophagitis, how exhaustive is your pursuit of alternative PPI options in these patients?